Dna-Probe, B And T Lymphocyte
The B and T lymphocyte DNA probe is a hematology in vitro diagnostic device used to detect and differentiate B-cell and T-cell lymphocyte populations through nucleic acid hybridization techniques, supporting diagnosis of lymphoid disorders. It is classified as FDA Class II under 21 CFR 864.5220 within the Hematology specialty, requiring 510(k) premarket clearance. The product code is MAM and the device is not implanted. Full GMP compliance is required and it is not eligible for third-party review.
Research product code MAM in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- MAM
- Device Class
- FDA class 2
- Regulation Number
- 864.5220
- Medical Specialty
- Hematology
- Review Panel
- HE
- Submission Type
- 1
Device Characteristics
510(k) Clearance History
Related 510(k) Clearances
This FDA classification is associated with 1 510(k) clearance via K numbers.
| K Number | Device Name | Decision Date | Decision | Applicant |
|---|---|---|---|---|
| K923951 | CD8 CYTOSPHERES KIT | Apr 25, 1994 | Substantially Equivalent | Coulter Electronics, Inc. |